See more : Charoen Pokphand Foods Public Company Limited (CPOF.F) Income Statement Analysis – Financial Results
Complete financial analysis of Cibus, Inc. (CBUS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cibus, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Smart Eye AB (publ) (SEYE.ST) Income Statement Analysis – Financial Results
- PT Tunas Baru Lampung Tbk (TBLA.JK) Income Statement Analysis – Financial Results
- Gold79 Mines Ltd. (AUSVF) Income Statement Analysis – Financial Results
- Ecrid, Inc. (ECDD) Income Statement Analysis – Financial Results
- SLM Solutions Group AG (AM3D.DE) Income Statement Analysis – Financial Results
Cibus, Inc. (CBUS)
About Cibus, Inc.
Cibus, Inc., a agricultural technology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company is based in San Diego, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.82M | 157.00K | 25.99M | 23.85M | 7.30M | 236.00K | 508.00K | 399.00K | 1.27M |
| Cost of Revenue | 395.00K | 1.53M | 28.56M | 35.13M | 9.28M | 1.08M | 551.00K | 200.00K | 751.00K |
| Gross Profit | 1.42M | -1.38M | -2.57M | -11.28M | -1.98M | -845.00K | -43.00K | 199.00K | 521.00K |
| Gross Profit Ratio | 78.26% | -877.07% | -9.89% | -47.28% | -27.19% | -358.05% | -8.46% | 49.87% | 40.96% |
| Research & Development | 42.37M | 11.55M | 11.34M | 11.08M | 12.21M | 9.85M | 11.56M | 5.64M | 2.77M |
| General & Administrative | 0.00 | 0.00 | 0.00 | 16.16M | 18.97M | 18.51M | 14.74M | 6.67M | 3.57M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 4.38M | 5.17M | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 28.91M | 10.97M | 15.38M | 20.54M | 24.14M | 18.51M | 14.74M | 6.67M | 3.57M |
| Other Expenses | 249.02M | 5.57M | 19.00K | -126.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 320.31M | 22.53M | 26.76M | 31.87M | 37.69M | 28.35M | 26.30M | 12.31M | 6.34M |
| Cost & Expenses | 320.70M | 22.53M | 55.32M | 67.00M | 46.97M | 28.35M | 26.30M | 12.51M | 7.09M |
| Interest Income | 527.00K | 60.00K | 17.00K | 557.00K | 1.60M | 1.52M | 0.00 | 0.00 | 0.00 |
| Interest Expense | 18.89M | 75.00K | 1.43M | 1.44M | 1.49M | 1.26M | 1.00K | 5.00K | 261.00K |
| Depreciation & Amortization | 4.69M | 1.53M | 2.34M | 1.87M | 1.61M | 1.08M | 551.00K | 345.00K | 147.00K |
| EBITDA | -314.59M | -15.21M | -25.43M | -41.53M | -36.52M | -25.56M | -25.43M | -11.74M | -5.48M |
| EBITDA Ratio | -17,313.43% | -14,248.41% | -109.75% | -170.19% | -499.81% | -10,810.59% | -4,968.11% | -2,948.37% | -445.52% |
| Operating Income | -318.88M | -22.37M | -29.33M | -43.83M | -39.67M | -28.12M | -25.79M | -12.11M | -5.81M |
| Operating Income Ratio | -17,549.97% | -14,248.41% | -112.87% | -183.77% | -543.76% | -11,913.14% | -5,076.57% | -3,034.84% | -457.08% |
| Total Other Income/Expenses | -18.76M | 5.48M | 133.00K | -1.00M | 61.00K | 218.00K | -191.00K | 23.00K | -75.00K |
| Income Before Tax | -337.64M | -16.89M | -29.20M | -44.84M | -39.61M | -27.90M | -25.98M | -12.09M | -5.89M |
| Income Before Tax Ratio | -18,582.44% | -10,758.60% | -112.36% | -187.98% | -542.93% | -11,820.76% | -5,114.17% | -3,029.07% | -462.97% |
| Income Tax Expense | -4.00K | -1.45M | -114.00K | 1.56M | 1.49M | 1.26M | 1.00K | 5.00K | 261.00K |
| Net Income | -267.63M | -16.89M | -29.20M | -44.84M | -39.61M | -27.90M | -25.98M | -12.09M | -5.89M |
| Net Income Ratio | -14,729.06% | -10,758.60% | -112.36% | -187.98% | -542.93% | -11,820.76% | -5,114.17% | -3,029.07% | -462.97% |
| EPS | -25.95 | -18.36 | -38.96 | -66.16 | -60.37 | -45.46 | -56.10 | -22.72 | -11.07 |
| EPS Diluted | -25.95 | -18.36 | -38.96 | -66.16 | -60.37 | -45.46 | -56.10 | -22.72 | -11.07 |
| Weighted Avg Shares Out | 10.31M | 919.95K | 749.52K | 677.65K | 656.11K | 613.67K | 463.07K | 532.00K | 532.00K |
| Weighted Avg Shares Out (Dil) | 10.31M | 919.95K | 749.52K | 677.65K | 656.11K | 613.67K | 463.07K | 532.00K | 532.00K |
Cibus, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights – CBUS
NEW YORK, NY / ACCESSWIRE / July 10, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cibus, Inc. ("Cibus, Inc.") (NASDAQ:CBUS) concerning possible violations of federal securities laws. Bonitas Research ("Bonitas") issued a report...
CBUS STOCK ALERT: Levi & Korsinsky Notifies Cibus, Inc. Investors of an Ongoing Investigation
NEW YORK, NY / ACCESSWIRE / July 10, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cibus, Inc. ("Cibus, Inc.") (NASDAQ:CBUS) concerning possible violations of federal securities laws. Bonitas Research ("Bonitas") issued a report...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cibus, Inc. - CBUS
NEW YORK , July 10, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cibus, Inc. ("Cibus" or the "Company") (NASDAQ: CBUS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
ATTENTION CBUS SHAREHOLDERS: Investors who lost money on Cibus, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation
NEW YORK, NY / ACCESSWIRE / July 10, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cibus, Inc. ("Cibus, Inc.") (NASDAQ:CBUS) concerning possible violations of federal securities laws. Bonitas Research ("Bonitas") issued a report...
Did Cibus, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - CBUS
NEW YORK, NY / ACCESSWIRE / July 9, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cibus, Inc. ("Cibus, Inc.") (NASDAQ:CBUS) concerning possible violations of federal securities laws. Bonitas Research ("Bonitas") issued a report...
Levi & Korsinsky Reminds Cibus, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - CBUS
NEW YORK, NY / ACCESSWIRE / July 7, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cibus, Inc. ("Cibus, Inc.") (NASDAQ:CBUS) concerning possible violations of federal securities laws. Bonitas Research ("Bonitas") issued a report...
Levi & Korsinsky Announces an Investigation on Behalf of Cibus, Inc. (CBUS) Shareholders Who May Have Been Affected by Fraud
NEW YORK, NY / ACCESSWIRE / July 7, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cibus, Inc. ("Cibus, Inc.") (NASDAQ:CBUS) concerning possible violations of federal securities laws. Bonitas Research ("Bonitas") issued a report...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cibus, Inc. - CBUS
NEW YORK, July 07, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Cibus, Inc. (“Cibus” or the “Company”) (NASDAQ: CBUS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
ATTENTION Cibus, Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights
NEW YORK, NY / ACCESSWIRE / July 5, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cibus, Inc. ("Cibus, Inc.") (NASDAQ:CBUS) concerning possible violations of federal securities laws. Bonitas Research ("Bonitas") issued a report...
Levi & Korsinsky Announces an Investigation on Behalf of Cibus, Inc. (CBUS) Shareholders Who May Have Been Affected by Fraud
NEW YORK, NY / ACCESSWIRE / July 5, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cibus, Inc. ("Cibus, Inc.") (NASDAQ:CBUS) concerning possible violations of federal securities laws. Bonitas Research ("Bonitas") issued a report...
Source: https://incomestatements.info
Category: Stock Reports